Germany: Johner Institute becomes part of GBA Group MedTech Solutions
Germany-based GBA Group, a leading independent TIC (Testing, Inspection, Certification) provider of bio-analytical laboratory services in the DACH region, has acquired a majority stake...
France: bioMérieux completes its offering for cell and gene therapies with acquisition of Accellix
France-based bioMérieux, a family-owned global leader in the field of in vitro diagnostics, has acquired the entire share capital of Accellix, increasing its stake from roughly...
India: Quadria Capital sells partial stake in Nephrocare’s IPO
Quadria Capital, one of Asia’s largest healthcare-focused private equity firms, has sold a partial stake in Nephrocare Health Services, one of the largest dialysis...
France: Archimed Diagnostics closes acquisition of ARK Diagnostics
Archimed Diagnostics has closed its carve-out of US-based ARK Diagnostics from listed South Korean specialty chemical company, Soulbrain Holdings. ARK is a global developer...
Belgium: Insta strengthens presence in PDMP market with acquisition of Prothya Biosolutions
Accord Healthcare’s Accord Plasma, a subsidiary of Indian multinational pharma Intas Pharmaceuticals, has completed the acquisition of Prothya Biosolutions Belgium and its subsidiaries. The...
Spain: Apheon partners with Longwood for future growth
Apheon, a pan-European mid-market private equity investor primarily investing in companies in Benelux, France, Germany, Italy and Spain, has acquired a majority stake in...
Belgium: AstraZeneca advances cell therapy ambition with US$1bn acquisition of EsoBiotec
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a Belgium-based biotech company pioneering in vivo cell therapies. The acquisition includes EsoBiotec’s Engineered NanoBody...
UK: Avacta agrees sale of Launch Diagnostics to Palex
LSE-listed Avacta Therapeutics, a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumour payloads directly to the tumour, has agreed...
Italy: Fremman Capital acquires majority stake in Diesse
Pan-European, mid-market investor, Fremman Capital, has acquired a majority stake in Diesse Diagnostica Senese, an Italy-based producer of diagnostic systems and dedicated reagents for...
Spain: Eurofins to acquire Synlab’s clinical diagnostics operations in Spain
Paris-listed Eurofins Scientific, a global scientific bioanalytical testing company with a developing presence in specialised and molecular clinical diagnostics testing and in-vitro diagnostic products,...
Advertisement
